Abstract
Introduction
Cardiac relaxation occurs when calcium is removed from the cytosol primarily through the actions of two Ž . proteins: the sarcoplasmic reticulum Ca-ATPase SERCA Ž . and the sarcolemmal Na-Ca exchanger NCX . The exchanger serves as the main calcium extrusion mechanism and is important in maintaining intracellular calcium w x homeostasis 1 . The relative contribution of SR Ca-ATPase Ž enter the cell, one Ca ion is expelled electrogenic trans-
. w x port 1,3 . The Na-Ca exchanger is encoded by three Ž . w x genes NCX1, NCX2 and NCX3 4-7 with a high degree of conservation at the nucleotide and protein levels between species, although it is the NCX1 gene which is w x primarily present in heart 8-15 . Hydropathy analysis shows that the protein generated from NCX1 derived transcripts has 11 membrane-spanning regions and, be-Ž . tween the 5th and 6th regions, a large 519 residue Ž . hydrophillic cytoplasmic loop domain has been proposed to contain sites involved in the regulation of exchanger w x activity, including those for Ca, Na and ATP 1,14,16 . Available evidence suggests that in heart the exchanger competes for Ca with the SR Ca-ATPase to bring about relaxation with about 10-30% of relaxation mediated by this route. This percentage varies with species and with w x developmental stage 2,17-19 . Effectively, the exchanger provides a mechanism of extruding Ca which enters the cell via the sarcolemmal voltage-dependent Ca channel w x 20,21 . At more positive membrane potentials, the exchanger contributes to the influx of Ca which may also w x bring about SR Ca release [22] [23] [24] . In heart, the NCX thus Ž . has two main roles: 1 control of the sarcoplasmic reticulum Ca content by regulating resting intracellular Ca lev-Ž . els; and 2 contribution to the entry calcium during the w x upstroke and plateau phases of the action potential 1 .
NCX expression and activity with growth and cardiac hypertrophy have been reported altered depending on the w x experimental setting [25] [26] [27] . An increase in NCX mRNA expression in the myocardium of patients with dilated Ž . Ž . cardiomyopathy DCM 55% increase or coronary artery Ž . Ž . disease CAD 41% increase , with a concurrent decrease in Ca-ATPase mRNA of 50% and 45%, respectively, has w x been demonstrated by Studer et al. 28 ; however, Komuro w x et al. 14 were unable to demonstrate any change relative to controls in NCX mRNA expression in either patients w x with DCM or CAD. At the protein level, Studer et al. 28 showed an increase in NCX expression with a concomitant decrease in Ca-ATPase expression. These results suggest that increased exchanger expression compensates for a reduced SR Ca-ATPase expression and function during heart failure. Consistent with the Studer study are the data from both rat and cat that show an increase in NCX w x expression 29 in response to pressure overload. During w x development, Boerth et al. 30 show much higher expres-Ž . sion 6-8-fold of NCX mRNA and protein relative to adults in a few selected time points of embryonic and Ž . newborn 1 day postnatal rat and rabbit hearts. The expression of exchanger mRNA peaks in both species near birth and declines postnatally, reciprocal to the mRNArprotein expression of the SR Ca-ATPase. These complementary temporal gradients in SERCA and NCX expression, as in failure, suggest a role for exchanger activity to compensate for lesser SR Ca-ATPase expression in the embryonicrearly postnatal state of developw x ment 2,31 .
What controls NCX cardiac gene expression? Changes in NCX expression around birth might be affected by the Ž . increase in circulating thyroid hormone TH just before birth. In hypothyroid rats the decline in cardiac NCX mRNA after birth is attenuated in comparison to normal w x w x animals 32 . Magyar et al. 33 observed that when adult hypothyroid rats are treated with TH, there is a concomitant decrease in NCX protein level to 64% of that seen in controls. NCX expression thus may be at least partially w x under the control of TH, either directly or indirectly 34 and the regulation appears transcriptional. As NCX is also involved in diverse physiological processes in many differw x ent tissues 9,12,14 , it might function andror be regulated differentially in different tissues. For example, the cardiac NCX controls intracellular calcium homeostasis; whereas in kidney, it drives the reabsorption of calcium and is responsible for maintaining extracellular calcium homeostasis. Tissue-specific alternative splicing of the mRNA w x transcripts has been reported 5,15,35-37 and in the cytoplasmic loop, alternative splicing results in some structural w x diversity among NCX clones in different tissues 11,36 . Functional comparisons between the cloned NCX cDNAs from heart and kidney, however, showed that the two molecules have essentially identical functional properties w x X 38 . The mRNA variants of the 5 -untranslated region in w x rat and a very recent publication from Menicks group 39 suggest a tissue-restricted use of different promoter controlling elements, maybe comparable to the rodent proenkephalin genes, Duchenne muscular dystrophy gene, w x or the human lck-gene [40] [41] [42] . NCX transcription is Ž . driven by at least three different promoters that give rise to three major and perhaps two minor forms of NCX transcripts, each differing in their 5 X untranslated regions w x 35 . Br2 transcripts are expressed in heart and brain, although only a shorter transcript has been described in heart. Br1 and Kc1 are not expressed in heart. Although the promoter regions for feline NCX have been reported in w x the literature 39 , very little is currently known about what Ž . regulatory factors cis andror trans might play a role in the control of the NCX transcriptional activity during development or during cardiac hypertrophy and failure or how tissue restricted promoters may regulate its expression.
Since cardiac hypertrophy and heart failure in rodent are known to involve re-expression of a number of gene products that are normally only seen during embryonic and fetal life, study of developmental aspects of gene expression provide essential evidence about potential regulatory mechanisms involved in cardiac hypertrophy and failure. The aim of this study was therefore to analyze the expression of this gene, the 5 X and 3 X splicing variants of the NCX1 gene products, and measure the transcriptional activity of the NCX1 gene during development. The results will then be compared with those reported here and by others in the senescent and pathophysiological myocardium. 
Methods

Animal models
Most of the studies were performed on Wistar rats Ž . Charles Rivers, UK except where noted in the text. For perinatal studies, timed pregnant rats were obtained and the fetuses taken from two to seven days before birth. Post-partum, neonatal rats were kept with their mothers until killed by decapitation at appropriate times after birth. Food and water were ad libitum. Five week old male Wistar rats were also obtained from Charles Rivers company where all visible thyroid-tissue had been removed Ž . surgically. The rats were then selected for A daily intra-Ž . peritoneal injections with 0.1 mgrkg thyroxine or B daily intraperitoneal saline injections. Animal welfare was in accordance with regulations established by the Home Office, UK. Animal preparations used for the induction of cardiac hypertrophy and hyperthyroidism have been dew x scribed elsewhere 43,44 . For in situ hybridizations and immunostainings, rats were obtained from HSD Animal Farm, Zeist, The Netherlands. Embryos were obtained from pregnant decapitated rats after CO inhalation. Also obtained were 7 and 25 2 postnatal days rats. Food and water were ad libitum. Animal welfare was in accordance with institutional guidelines of the University of Amsterdam.
RNA
Total RNA was isolated from rat left ventricles or whole heart for perinatal developmental studies according w x to the methods of Chomczynski and Sacchi 45 . RNA quality was checked by electrophoresis and quantities were determined by absorbance at 260 and 280 nm in a cuvette Ž . q with a 1 cm light path. Poly A RNA was isolated using Ž . the PolyATract IV system Promega and the integrity and quantity checked by Northern blots. Cardiac RNA obtained from Wistar rats for the study of senescence were also kindly provided by Dr. E. Lakatta.
Ž . q For Northern blots, 100 ng of poly A RNA or 20 mg of total RNA were separated on a 1% denaturing formalq Ž . dehyde gel and transferred to Hybond N Amersham in Ž . w x 10 = SSC sodium chloride, sodium citrate overnight 46 . After fixing, the blot was prehybridized for 20 min in Ž . Express Hybe-solution Clontech , hybridized for 1 h at Ž . 688C with random labelled probe pRCNCX10 , sequentially washed to a final stringency of 0.1 = SSC, 0.05% SDS at 508C and exposed to film. NCX mRNA levels were determined by Northern blotting to ensure hybridizaw x tion to a single band of appropriate molecular weight 46 .
NCX clones
cDNA library screening
cDNA clones to rat NCX were isolated and characterw x 6 ized as previously described 47 . Briefly, about 5 = 10 phages of a rat cDNA library were plated, plaque lifts prepared and screened with a 32 P-labelled cDNA probe Ž . generously provided by Thomas Eschenhagen Hamburg . Ž Following washes with 1 = SSPE 180 mM NaCl, 10 mM . sodium phosphate, and 1 mM EDTA , 0.1% sodium dode-Ž . Ž . cyl sulfate SDS at 658C, 12 plaque forming units pfu were identified and further analyzed. All of the clones turned out to be identical and were sequenced to comple-Ž tion by use of the Sequenase kit Amersham, Little Chal-. font, UK and as primers oligonucleotides corresponding to the KS and SK sequences of pBluescript and internal sequences constructed for this purpose.
Genomic screening
After infection of LE392 cells, a rat genomic l Dash Ž .
2 library Stratagene was plated at a density of 300 pfurcm Ž 6 . Ž q . total: 10 pfu . Double filter lifts Hybond N were taken, denatured, neutralized and fixed according to standard procedures. The filters were prehybridized over night at 658C in 5= SSPE, 0.5% SDS, 5 = Denhardt's solution and 100 mgrml denatured herrings sperm DNA. A ran-( . dom labelled probe PstIrRsaI digestion of clone M16 Ž . was prepared using the Random Priming Kit Amersham , added to a concentration of 7.5 = 10 6 countsrfilter and hybridized for 24 h at 658C. The filters were extensively washed in 3 = SSPE, 0.1% SDS at RT and 2 = SSPE, 0.1% SDS at 408C and exposed to film for up to 2 days at y708C. Only double positive signals were subjected to two additional rounds of screening, which resulted in isolated plaques for 5 positive clones. Phage DNA was w x prepared following a standard protocol 48 .
Approximately 2 mg of phage were digested with EcoRI and 'shot-gun' subcloned into EcoRI linearized and phosphatase treated pBluescript SK vector. Positive clones were identified by colony-lifts using end-labelled NCE57 Ž . see below as probe. DNA was prepared using kits from Ž . Ž either Qiagen Ltd. Maxipreps or Promega Wizard . Minipreps and sequenced. The resulting sequence was screened for transcription-factor consensus binding sequences using on-line MatInspector and TESS.
Western blots and immunostaining
Protein preparation and Western blots were performed w x essentially as previously described 28 . Briefly, 50-150 mg of frozen tissue was homogenized three times for 10 s Ž in 7 volumes of lysis buffer 20 mM Hepes, 4 EGTA, 1 mM DTT, pH 7.5 containing freshly added 1 mM PMSF . Ž and 0.3 mM Leupeptin using a Polytron Kinematica, . Luzern . The samples were mixed for 1 h at 48C and subsequently centrifuged at 38C for 1 h at 100 000 = g in a Sorvall OTD Combi. The supernatant was removed and the samples redissolved in 7 volumes of lysis buffer and homogenized with a hand homogenizer. Aliquots were frozen at y808C. body , against canine sarcolemmal Na rCa exchanger Ž . w x Swant, Switzerland 52 . The antigene-antibody was visualized using the indirect unconjugated peroxidase-antiperoxidase technique. Incubations were performed at room w x temperature as previously described 49 . Sections were studied with a light microscope, using bright-field illumination. using 5 = 10 cpm NCX probe and 2-5 = 10 GAPDH probe per reaction. For the 5 X specific probe M16, the RPAs were performed with slight modifications. Hy-Ž . q bridization was to approximately 100 ng of poly A RNA, 5 mg total heart RNA and 15 mg brain and kidney RNA using 10 5 cpm of probe. The RNA and probe were allowed to hybridize overnight, followed by RNase digestions in the presence of 1:100 dilution of the RNase A and RNase T1 mix provided in the RPAII kit, for 30 min. After separation on a 6% denaturing polyacrylamide gel, dried gels were exposed to X-ray film for between 2 h and 1 week or quantitated using a phosphoimager. For clone M16, RNase digested protected fragments were precipitated in ethanol after addition of carrier yeast tRNA, dissolved in loading buffer and separated on a 7.5% denaturing polyacrylamide gel. 
. Quantification of MHC iso-mRNAs: 53,54
Complimentary DNA was synthesized from 2 mg of total RNA using a first strand cDNA synthesis kit with Ž . oligo dT 18 as primer, according to the manufacturer's Ž . instructions Pharmacia . Once complete, 1 ml of the reverse transcriptase reaction was used for PCR amplifica-Ž tion with forward GAG GCG GTG CAG GAG TGT . Ž . AG and reverse GTT GGC CTG TTC CTC CGC C oligonucleotides identical to both a-and b-MHC, as prew x viously described 53,54 with slight modifications: 5 min 958C, 2 cycles at 45 s 958C, 30 s at 658C and 35 s at 728C and 18 cycles at 45 s 958C, 30 s 638C and 35 s 728C. The amplified MHC iso-RNA's were distinguished by Tru 91 restriction enzyme digestion and the fragments separated on a 6% denaturing acrylamide gel, run for 4 h at 1700 V, dried and subjected to phosphoimaging, and ratios between complementary isoforms were calculated.
.2. 5 UTR RT-PCR nested
Complimentary DNA was synthesized as above from 1 mg of total RNA derived from different developmental stages of heart or other tissues. GCC ATG CTT AGA GAC corresponds to y165 to w x y142 bp of the published Br2 clone 35 and the antisense Ž primer NCE56: CCA CCA GAG TTA CCA GAC . GAA ATC CC to q61 to q36 bp compared to the deduced start of translation. 1 ml of the first round of PCR served as template for the nested PCR using as sense Ž primer either NCE21 CAG CCA TGC TTA GAG . Ž ACC; y155 to y138 bp or NCE20 AGC CTT CGG . AGC GAG TTG G; y91 to y73 bp , and as antisense Ž primer NCE17 GGT GGG AGA CTT AGT CGA; q6 . to q23 bp . The second round of PCR was performed under the following conditions: 1 cycle for 5 min at 958C, 45 s at 568C, 30 s 728C, 10 cycles at 45 s 958C, 45 s at 548C, 30 s at 728C and 15 cycles at 45 s 958C, 45 s 528C and 30 s 728C. Products from both rounds of PCR were separated via a 2% agarose gel, resulting bands cut out, Ž . eluted via spincolumns Sigma and subcloned into T-tailed EcoRV digested pBluescript SK vector. Positive clones were identified by colony-lifts, grown and DNA prepared and sequenced. Cardiac clone M16, derived from the first round of PCR, displays a sequence so far only detected in Ž . brain Br2 , and was mainly used for subsequent experi-Ž . ments RPA, Genoblot and genomic screening . Cardiac clone M X T X , derived from the nested PCR, contained a 5 X UTR exon of 130 bp not previously described.
Loop splicing RT-PCR
Complimentary DNA was synthesized as above from 0.5, 3 or 2 mg of total heart, brain and kidney RNA, Ž . q respectively, or 50 ng of poly A RNA. The primers Ž correspond to nucleotide 1651-1674 NCE51: GGC ATC . ATG GAG GTG AAG GTG CTG and 2064-2041 Ž . NCE55: GCT GGT CAG TGG CTG CTT GTC ATC according to the deduced translation start in the rat heart Ž . cDNA accession No. X68191 and following amplification generating a 414 bp fragment from rat heart RNA. Three ml of the transcription reaction, 0.1 mM each dNTP and 15 pmol of each primer total, including 2 pmol of end-labelled NCE55, were used in a reaction volume of 50 ml. The PCR was carried out under stringent conditions: 5 min 958C, 8 cycles at 45 s 958C, 30 s at 708C and 30 s at 728C, 14 cycles at 45 s 958C, 30 s 688C and 30 s 728C. Twenty ml of the PCR reaction were separated on an 8% denaturing acrylamide gel, the gel dried, exposed to film and phosphoimaged.
Genomic clonal analysis and DNA blotting 2.7.1. Genomic blot
A rat Genoblot was purchased from Clontech Inc. After 6 h of prehybridization at 658C in 5= SSPE, 10 = Denhardt's, 2% SDS and 40 mgrml denatured herrings sperm DNA, 10 6 cpmrml probe was added. The probe Ž was generated from a M16rPstIrRsaI gel-purified y165
. w 32 x to y51 bp and MCS fragment. a-P dATP was incorporated using the specific, end-labelled primers NCE47 Ž and NCE57 CCG TCT CTG TCT GCA GGG GCT . GGA TGA GAA AC, y41 to y73 bp in a standard Klenow reaction. The Genoblot was hybridized for 24 h at 658C and washed up to a stringency of 2 = SSPE, 0.1% SDS at 508C.
Phage Southern blots
Phage DNA was digested with EcoRI and SacI and fractioned over a 0.8% agarose gel. The gel was depurinated, denatured, neutralized and dry blotted onto two Ž . mirror-image nylon membranes. The membranes were then hybridized according to established protocols at 658C with the M16rPstIrRsaI fragment or at 558C using labelled NCE56, washed at moderate stringency and exposed to film.
Tissue processing
Fetal and neonatal tissue was fixed in a freshly prepared Ž . Ž formaldehyde FA solution 4% paraformaldehyde Ž . . weightrvolume in sterile PBS, pH 7.4 for 4-5 h at 48C. The tissues were left overnight in 70% alcohol at room temperature. The specimens were dehydrated in a graded alcohol series at room temperature and were left overnight in 1-butanol or chloroform. During fixation and dehydration tissue specimens were placed on a shaking platform. Subsequently the specimens were embedded in Paraplast Ž . Plus Sherwood Medical Co., St. Louis, MO, USA , sec-Ž . tioned 7 mm thick and mounted onto 3-aminopro-Ž . pyltriethoxysilane Sigma -coated slides for in situ hybridization.
In situ hybridization
Pretreatment, hybridization, processing of autoradiography of sections and preparation of probes were perw x formed as described elsewhere 55,56 . Per section, approximately 6 ml of hybridization mixture was applied. After hybridization the sections were rinsed with 1 = SSC and washed twice at 528C in 1= SSCr50% formamide for Ž . 10 min in RNaseA 10 mgrml for 30 min at 378C, twice in 1 = SSC for 10 min and finally in 0.1 = SSC for 10 min. Hereafter, sections were dehydrated, air-dried, cov-Ž ered with photographic emulsion Nuclear Research Emul-. sion G5, UK and exposed for 7-10 days. After development for 4-8-min sections were slightly stained with nuclear fast red, dehydrated, mounted in Malinol and studied, using bright-field microscopy. 35 S-labelled cRNA probes to SERCA2 and NCX mRNA were made by in vitro transcription as previously described w x 56 , using pBS as a vector containing the 2200 bp EcoR1 cDNA fragment of the 3 X end of rat cardiac SERCA2 w x generated from clone pRH39 57 and the 500 bp . Ž . banded rats is 9 and 10, respectively P -0.001 . B Hypothyroidism. Rats were made hypothyroid by surgical thyroid-parathyroidec-Ž . tomy. NCX mRNA in hypothyroid ns 3 myocardium is more than Ž .Ž ) ) ) . 2-fold elevated compared to euthyroid rats ns 7 P -0.001 . For an example of the raw data, see Fig. 2 . than 200 nucleotides were subjected to alkaline hydrolysis to yield fragments with a mean size of approximately 100 w x nts 55 . Control reactions included hybridization with sense probes of each of the cRNAs tested and pretreatment Ž . with RNaseA 20 mgrml, 30 min, 378C .
Nuclear run-ons 2.10.1. Isolation of myocardial nuclei
Total cardiac nuclei were isolated using a modification w x of the techniques of Long et al. 58 . Briefly, ventricles obtained from 1 to 7 litters of embryonic rats or from 5 to 20 pups of postnatal animals were rinsed in ice-cold saline. All subsequent steps were performed at 48C. After rinsing, approximately 0.75-1.0 g of tissue was homogenized in Ž Ž 12.5 ml of buffer NA 300 mM sucrose, 10 mM Tris pH . Ž. . Triton X-100, 0.1 mM PMSF, 15 unitsrml rRNasin . This mixture was layered onto a 15 ml cushion of buffer NB and centrifuged in a SW 28 Beckman rotor at 25 000 rpm for 1 h at 48C. After centrifugation, all but 2.5 ml of the supernatant was removed, to which was added 20 ml NA without Triton X-100. After mixing, this was centrifuged at 2000 = g for 20 min, the supernatant discarded and the Ž resulting pellet resuspended in 1.5 ml of NA buffer without . Triton X-100 , a fraction of which was analyzed to deterw x mine the number of nuclei isolated 59 . The remainder of the nucleirBuffer NA was centrifuged at 5000 rpm in an Eppendorf microcentrifuge for 5 min, the supernatant disw x carded, the pellet resuspended in Keller storage buffer 59 , frozen in liquid nitrogen and stored at y808C.
In Õitro transcription
Nuclear transcription assays and hybridizations were performed with minor modifications as previously dew x Ž 6 7 . scribed 59 Briefly, isolated nuclei 5 = 10 to 1 = 10 Ž . were added to a mix containing 40 mM Tris-HCl pH 8.3 , 150 mM NH Cl, 7.5 mM MgCl , 0.625 mM ATP, 0.313 4 2 w 32 x Ž mM each of GTP and CTP, and 0.5 mCi P UTP 800 . Cirmmol, Du Pont and 1200 unitsrml recombinant Ž .Ž . RNasin rRNasin Promega . Reactions were incubated at 278C for 20 min. At times 0, 5 min, 10 min and 20 min, the reaction was mixed by gentle trituration and 2 ml taken for measurement of radionucleotide incorporation by DE-81 filter washes. At the end of the 20-min incubation period, the reaction was stopped by addition of 75 units RQ1 Ž . DNase Promega and 40 units of rRNasin by incubation at 278C for 15 min. The reaction was then centrifuged for 2 min at 5000 rpm in an Eppendorf microcentrifuge, the supernatant discarded and the pellet resuspended in 500 ml Ž . of guanidinium thiocyanate denaturing solution GuSCN Ž4 M guanidinium thiocyanate, 25 mM Na citrate, pH 7.0, . 0.5% N-lauroylsarcosine, 0.1 M b-mercaptoethanol . To this was added 50 ml 2 M Na acetate, 500 ml of water saturated phenol, and 100 ml chloroformrisoamyl alcohol Ž . 49:1 . The tube was vortexed after each addition, left on The animals were injected daily with 0.1 mgrkg thyroxine or saline for the controls and sacrificed at the indicated time points after the first Ž . injection. Each group ns 4; except 7 days: ns 3 was compared to the control group. ) P -0.05. ice for 20 min, and centrifuged at 12 000 rpm for 20 min at room temperature. The aqueous phase was precipitated with an equal volume of isopropanol, centrifuged and the resulting pellet washed with 70% ethanol. Subsequently the pellet was resuspended in 100 ml of GuSCN solution, re-precipitated with an equal volume of isopropanol overnight, centrifuged as above, and the pellet resuspended Ž Ž . . in 100 ml of TE 10 mM Tris, 1 mM EDTA pH 8.0 . Ž . A Bio-Dot SF Bio-Rad Laboratories apparatus was used to prepare the slot blots containing the denatured Ž plasmid pRCNCX8r10, pFIN a-cardiac actin specific
. w x plasmid 59 , pGAPDH and as a negative control the Ž . plasmid pBluescript Stratagene . Five micrograms of each plasmid were made up to a final volume of 50 ml with water and 3 ml of 5 M NaOH added. This was incubated at 958C for 10 min and allowed to cool for 5 min. Fifty ml of 4 M ammonium acetate was added to the mix, vortexed and 50 ml added to each slot of hybond N q nylon mem-Ž . branes Amersham . Once added, the slot was rinsed 2 times with 50 ml of 1 M ammonium acetate and then rinsed with 2 = SSC. The membrane was dried and UV Ž . fixed with a Stratalinker Stratagene .
Probe annealing to the nylon membranes containing specific sequences for NCX was performed by addition of 5 = 10 5 cpmrml labelled transcripts to 10 ml of a pre-hybridization solution containing 50% deionized formamide, Fig. 3 . NCX transcripts in aging myocardium. Data were obtained from RPA assays. The mRNA levels for cardiac NCX are lowest at 6 and 18 months, however, a significant increase in NCXrGAPDH ratio can be detected in 24 month old senescent rat heart. ANOVA, ) P -0.05, ns6 for all timepoints. Hybridization efficiencies were as previously described w x 60 and found to be comparable to that reported for other cDNA probes.
Statistical analysis
All data were expressed as means " S.E.M. In the statistical analyses, the data groups were compared using 
Significance was taken at P -0.05.
Results
RNA abundance in pathophysiological hearts
NCX transcripts have been shown to have an altered abundance in cardiac hypertrophy and in hypothyroid animals. To ensure that the RNase Protection Assays examining NCX transcripts and normalized to GAPDH transcripts gave similar results to those previously published, labelled cRNA probes were hybridized to 5 mg of total cardiac RNA isolated from rats with aortic constriction or which were hypothyroid. In rats subjected to an ascending aortic constriction and with a cardiac hypertrophy of between 40 and 80%, a 100% increase in NCX transcripts could be Ž demonstrated 3 weeks after aortic constriction Fig. 1A ,
. w x P -0.05 , similar to that reported by others 28,29 . Two groups of hypothyroid rats were also studied. The first group had severe hypothyroidism characterized by a pure b-MHC mRNA expression in heart and the second had mild hypothyroidism having both b-and a-MHC gene Ž . expression data not shown . In the group of severely hypothyroid Sprague-Dawley rats, NCX expression was elevated relative to age matched controls by more than Ž .Ž . 2-fold P -0.05 Fig. 1B . In mildly hypothyroid Wistar rats treated with thyroxine, no significant change in NCX expression could be seen during the first 4 days following thyroxine injection but after seven days of thyroxine injec-Ž tion a decrease in NCX transcripts of almost 30% Table  . Ž . 1 was seen P -0.05, ANOVA . In the mildly hypothyroid controls, b-MHC mRNA expression was elevated relative to euthyroid controls and a-MHC transcripts remained in abundance. The expression of b-MHC was rapidly reduced following thyroxine injections. These re-Ž . sults demonstrate that thyroxine injections 0.1 mgrkg returned MHC gene expression towards that seen in euthyroid animals and could modify the abundance of NCX transcripts. The effects on NCX abundance, however, seem to be slower indicating a latent or a potentially indirect effect of thyroid hormone on NCX gene expression. As these results are consistent with those previously published w x 61,62 , we conclude that the RPA assay system is appropriate for measuring changes in NCX expression with development and aging, and that NCX mRNA expression can be modified by pressure overload or by thyroid hormone status.
Analysis of NCX expression in deÕelopment and with senescence 3.2.1. RNA transcripts
To have a more complete profile of NCX RNA expression with development, we investigated the perinatal expression of cardiac NCX mRNA from 15 ED onwards, the results of which are shown in Fig. 2 . In the late fetal rat myocardium, NCX mRNA is always expressed at levels Ž ) 2-fold above those seen in 13 week old adults P -0.05, . ANOVA . Maximal expression occurs at 18 embryonic Ž . days 4.6-fold above adult levels . No statistically significant difference could be demonstrated between any of the fetal time points examined and the 1 day old neonates. After birth NCX expression decreases rapidly, and by 20 ND there is no statistically significant difference in the presence of this RNA with that of 13 week old adult.
To study the effects of aging, NCX mRNA expression Ž was also examined in 2, 6, 18 and 24 month old rats Fig. . 3 . Between 2 and 6 or 2 and 18 months, a 20% decrease Ž . in NCX expression can be demonstrated P ) 0.05 . In fact the lowest levels of NCX RNA were seen in these two groups. At 24 months of age, NCX expression increases by Ž almost 50% above that seen at 6 or 18 months P -0.05 Ž . for both age groups, ANOVA and is fully 20% greater Ž . than that seen at 2 months of age P ) 0.05 . When compared with the perinatal period at 20 ED or 15 ND, NCX expression is significantly reduced in 2, 6 and 18 month old animals but is not different from that seen at 24 months of age. These data demonstrate an increased abundance of NCX transcripts with senescence.
To examine the spatial distribution of NCX transcripts with development, in situ hybridizations were performed on serial sections of samples prepared from embryonic, Ž . fetal and postnatal rats Fig. 4 . As negative controls, Ž . sections were RNase treated Fig. 4 . Specific NCX ex-Ž . pression was seen from the 10 embryonic day ED looping heart stage onward. Hybridization was almost homogenous throughout the heart in all stages studied. In the post natal rat heart, NCX transcripts are still detectable at 7 days after birth, but by 25 neonatal days, virtually no expression is detectable in the myocardium. In contrast, SERCA2a shows a gradient of expression from 10 EDs, being higher in the inflow tract and atrial regions that Ž . persists even into adult myocardium data not shown . The signal intensity for SERCA2 transcripts increases in late fetal and in neonatal rat hearts, in contrast to that seen for NCX. The distinct SERCA2 expression as compared to the NCX expression underscores the specificity of the hybridization. RNase treatment resulted in the disappearance of the hybridization signal.
Protein
Western blots were performed to examine the protein abundance in late fetal and postnatal rat hearts. The antibody p was used to examine membrane preparations of cardiac tissue isolated from day 17 embryonic to 18 week old adults. As can be seen in Fig. 5A and Fig. 5B , exchanger protein is most prominent at 19 ED. Postnatally, the abundance decreases to adult levels sometime between 3 and 18 weeks of age. Adult myocardium contains 6.5-fold Ž . less exchanger than late embryonic heart P -0.05 . The pattern of expression is very reminiscent to that seen for RNA, suggesting that the regulation of Na-Ca exchanger protein abundance is pre-translational.
To examine the spatial distribution of NCX proteins with development, immunostaining of cardiac tissue sections were performed. As with the in situ hybridizations, embryonic, fetal and postnatal hearts were examined. As shown in Fig. 6 , each of the sections showed a homogenously positive signal. No compartmentalized loss of protein was detected by this method in either fetal or adult atria or ventricles. In the absence of primary antibody, no signal could be detected. Unlike the loss of RNA signal in 25 day old rats, the protein is still strongly positive, 6 cpm, 1.8=10 6 cpm, 1.85=10 6 and 2.7=10 6 cpm, respectively, were hybridized to plasmids immobilized on nylon membranes. In the case of pBS, no signal was detectable. A strong signal was seen at each of the time points examined Ž . for cardiac actin and GAPDH. At 17 embryonic days ED , a strong Ž . positive signal was seen with pRCNCX8. At 1 and 5 neonatal days ND , only a very weak signals could be seen. No signal was ever seen for NCX at 20ND.
suggesting that the protein has a longer half-life than that of the RNA. These data are in agreement with those found by Western analyses.
Transcriptional regulation
The RNA and protein results presented above indicate a pretranslational level of control for NCX1 gene products. Nuclear run-on assays were therefore used to distinguish between transcriptional or post-transcriptional mechanisms Žnuclear processing, export from the nucleus, or half-life in . the cytoplasm . The radioactive incorporation into total neonascent RNA transcripts did not differ between any of Ž . the time points, although a downward trend P ) 0.05 in the overall incorporation occurred between 1 and 20 NDs Ž . data not shown . The results of one set of nuclear run-on experiments are shown in Fig. 7 . In late fetal hearts the incorporation into NCX transcripts as expressed in parts Ž . per million ppm was, in general, lower than that seen in the 1 ND rat heart, where the highest incorporation was seen. At 5 ND, one sample had a very high level of expression comparable to that seen in the 1 ND animals, but the other samples had almost no detectable activity. By 20 ND, neo-nascent transcripts for NCX could not be detected in any of the run-on assays, indicating a strong decrease in its transcriptional activity in the postnatal Ž period P -0.05 compared to all other time points mea- Ž . Data are presented in parts per million ppm or as a ratio with either cardiac actin or GAPDH. Hybridization efficiencies were on average 17.5% under the washing conditions used and did not differ Ž . between the individual groups. For calculation of gene-specific hybridization in parts per million ppm , the counts per min hybridized to each probe were corrected for the nonspecific background and for 100% hybridization efficiency before they were divided by the amount of labeled RNA that was included in the respective hybridization reaction. ) P -0.05 relative to 17-18 ED; a P -0.05 relative to 1 ND. † ns1 due to nonspecific signals.
at Pennsylvania State University on http://cardiovascres.oxfordjournals.org/ Downloaded from ( )X Ž . Fig. 8 . Examination of the 5 region of NCX transcripts. A Example of a representative RPA using the RT-PCR derived, 5 X UTR clone M16 as a template. In this image at least six bands are visible: The longest protected fragment is 226 bp and indicates the use of a transcription start Ž site that has previously only been detected in brain approximately y178 . bp . Four smaller fragments, ranging from 162 to 180 bp, correspond to Ž the cardiac specific transcription start points, with 162 bp y101 bases . from translation start being the major start site. The 92 bp fragment, which can also be seen in brain and kidney, indicated the existence of a unique 5 X splice variant in heart. Lanes: A, 50 bp ladder; B, ED19 polyA; C, ED20 polyA; D, NN polyA; E, adult heart polyA; F, ED19 cardiac total RNA; G, adult cardiac total RNA; H, brain total RNA; I, kidney Ž . total RNA. Lanes J and K show the negative probeqRNase and Ž . Ž. positive undigested probe control for the probe, respectively. B Se-Ž X X . quence for one of the alternatively spliced isoforms clone M T , resulting in the 92 bp protected fragment. The newly discovered 130 bp exon Ž . bold is spliced in between the first coding exon and the Br2 exon Ž . italic . The position is given according to the startsite of translation Ž . underlined .
. sured . By comparison, both cardiac a-actin and GAPDH were actively transcribed at each time point examined, including at 20 neonatal days. These data conclusively show that NCX transcription decreases after birth. No significant difference in the transcriptional activity of cardiac a-actin could be demonstrated between any of the Ž . time points examined Table 2 ; however, the level of GAPDH transcription found the post-partum rat heart was less than that measured in the fetal rat heart.
Transcription start sites
NCX has been shown to use different, tissue specific 5 X untranslated exons, leading to the hypothesis that multiple, tissue specific promoters may exist. We wished to examine the possibility that these different mRNA variants and recently discovered splice sites might be regulated during development. Subcloning and sequencing of a rare cardiac Ž . RT-PCR product M16, y165 to q61 revealed that the 'brain-specific' Br2 exon is also transcribed in heart. Ž . Using this PCR amplified product M16 , further RPA analyses were performed. After hybridization, at least five transcription start sites were seen in heart tissue. Four predominant fragments were seen with sizes of 180, 175, Ž . 171 and 162 bases Fig. 8 . The major transcription site Ž corresponded to the 162 base fragment y101 bases rela-. tive to translation start site and to a somewhat lesser Ž . extent the 171 base fragment y110 bp . These sites were used 56-63% and 18-20% of the time, respectively. The two other minor bands were used to a lesser extent, but never more than 6% of the time. Each of the four bands were detected in ventricle and atria, and there was no apparent transition in the relative abundance of the sites used to initiate transcription during the course of development. A fifth protected fragment was also identified that Ž . had a length of 226 nucleotides y165 bp , but was Fig. 9 . Examination of the 3 X loop region of NCX. Assays were performed by RT-PCR using primers NCE51 and NCE55 to examine this alternatively spliced region. The major heart isoform gives rise to the longest product of 411 bp. Four additional minor bands can be detected in this figure, indicating the existence of at least three more than the two so far reported isoforms. At least three of the isoforms seem to co-migrate with brain derived isoforms. Lanes: A, 50 bp ladder; B, negative control; C, ED19 polyA; D, ED20 polyA; E, NN; F, adult heart polyA; G, adult cardiac total RNA; H and I, brain total RNA; J, kidney total RNA. probably longer and was limited by the length of the M16 probe. This potential upstream start site of transcription had not been reported previously in the heart and corre-Ž sponded to a mRNA variant that is present in brain y178 . bp . This transcript was expressed at all time points examined. It was, however, slightly more abundant in the adult Ž myocardium 1.6-1.8% in embryonic heart versus 3.0-. 3.8% in adult , suggesting that use of this transcription start site was developmentally regulated. These data were further confirmed by primer extension analyses and se-X Ž quencing of the fragment as well as 5 RACE data not . shown .
Splicing at the 5 X end and at the carboxy-terminus of the loop with deÕelopment
We have detected the presence of an alternatively spliced mRNA variant in the 5 X untranslated region of cardiac NCX transcripts. A 92 base pair protected fragment in the RPA, which is present in heart in addition to brain and kidney, suggested the existence of at least one 5
X alternatively spliced cardiac product. This variant arises from a X Ž . novel 130 bp 5 untranslated exon Fig. 8 , which is located between the first coding exon and the upstream Ž X X . Br2 exon clone M T . The intronrexon boundary of this spliced fragment is located correctly at position y31. The Ž . usage of this site approximately 10% was detected in fetal and adult heart, but no developmental regulation could be demonstrated.
The carboxy-terminus of the cytosolic loop has been reported to have tissue restricted patterns of splicing. This region is of particular interest since it occurs in the coding region of the mRNA. We therefore examined this region for any developmental changes in the usage of the various exons. The major known cardiac PCR product should have a length of 414 nucleotides according to the rat cardiac Ž . cDNA accession No. X68191 , or 411 bases according to w x Lee et al. 35 , the latter size corresponding to our finding. Although only two cardiac splice variants had been previw x ously identified in heart 35,37 , we report the existence of at least six differentially spliced isoforms in rat heart. The results are shown in Fig. 9 and Table 3 . The largest Ž . isoform generated a band of 411 414 bp which accounted for about 45 to 65% of the transcripts. From sequence analysis, two new splicing patterns using known splicing Ž . cassettes were identified Table 3 , and three others have yet to be sequenced. At least one of these variants may be expressed in brain, suggesting that their origins may be within the cells innervating the heart. With development, no change in the overall expression pattern of these transcripts could be detected.
Genomic clones
Since NCX expression is transcriptionally regulated during the perinatal period, isolation of the 'cardiac-restricted' promoter elements was essential. The screening of Ž . . not shown . These clones are very similar to those recently w x described by J. Lyttons lab 63 . Subcloning of the phage EcoRI digest has allowed us to sequence and analyze this Ž . NCX promoter region Fig. 10 . As can be seen in this figure, we have identified one consensus thyroid hormone responsive elements half site and a number of GATA consensus sequences. Three GATA sequences are located in the proximal promoter. Four additional GATA sites are of further interest because of their close proximity to Ž NKX2.5 binding sites GATA: y1966, y1985, y2287, y2366; NKX2.5: y1985, y1992, y2061, y2349, . y2358 . In preliminary experiments, a 2.8 kb PstI frag-Ž ment has also been cloned into pGL3 Basic vector Pro-. mega and when transfected into cardiomyocytes shows a 7-fold increase in luciferase activity over controls. This promoter is therefore sufficient for driving cardiac transcription in vitro.
Discussion
We have examined rat cardiac Na-Ca exchanger mRNA and protein expression, both temporally and spatially during fetal and neonatal cardiac development. The exchanger is already abundant in the looping embryonic heart, throughout late embryonic and fetal cardiac development and at birth; it then rapidly declines in the postnatal myocardium. RNA abundance increases again in senescence. Developmentally, its expression appears to be regu-Ž . lated transcriptionally nuclear run-on assays ; however, the half-life of the protein appears to be much longer than that for the message, accounting for the continued immunostaining of NCX in 25 day old neonates when neither transcription nor abundant levels of message can be measured.
We have employed the techniques of run-on assays using cardiac nuclei prepared from the same litters as those used in the perinatal study of NCX mRNA expression; however, due to the difficulty of these experiments, fewer time points were analyzed. During the late fetal and early postnatal period, no significant difference in the transcriptional activity of the NCX gene could be detected, but by 20 ND, no transcriptional activity could be detected. These results are very similar to the pattern of expression seen for NCX mRNA accumulation: as the transcription decreases, NCX transcripts decrease in abundance albeit more slowly; however, in 3 month old rat hearts, NCX transcripts are detectable whereas no transcription from the gene can be demonstrated at 20 neonatal days. The apparent difference in the results are probably due to the sensitivity of the two methods, where RPA is a liquid based hybridization technique versus the less efficient membrane hybridization system employed for the run-on assays. This finding is supported by data from in situ hybridizations where the transcripts for NCX are easily detectable in sections of fetal and early neonatal rat hearts, but which are almost undetectable in the 25 ND rat hearts. As such, the measured decrease in transcriptional activity appears to be predictive of a subsequent decrease in mRNA expression. Alternatively, the results could be interpreted to mean that in the late perinatal period when the transcriptional activity is very low, the maintenance of this transcript's accumulation might be due to post-transcriptional regulatory mechanisms, perhaps affecting the half-life of the mRNA. We can not, however, prove this possibility since we have not actually measured the half-life of this transcript in vivo. We can, however, conclude unequivocally that NCX transcriptional activity decreases after birth accounting for some of the altered abundance seen perinatally.
Changes in SR Ca-ATPase and Na-Ca exchanger protein abundance provide a molecular basis for why adult rat ventricle is more SR reliant than neonatal rat ventricle and why atria are generally more dependent on SR Ca release w x than ventricle 2 . In the fetal myocardium, NCX protein abundance is 6.5-fold greater than that in the adult myocardium, and the exchanger is evenly distributed throughout the embryonic and early fetal heart, unlike the SR Ca-ATPase which is more abundant in atria than ventricle w x 56,64 . After birth the decline in exchanger protein is paralleled by an increase in SERCA2 expression throughw x out the heart 31 . The contribution of the exchanger in determining relaxation rate correspondingly diminishes as w x the SR Ca-ATPase becomes more abundant 2,18 . Given the importance of the exchanger in maintaining intracellular calcium homeostasis, these results also predict that when Na-Ca exchanger is abundant relative to the amount of SR Ca-ATPase, extracellular calcium should play a relatively more important role in initiating myocardial contraction. In the embryonic heart, for example, initiation of contraction should be less dependent upon calcium-induced calcium release from SR stores. A greater proportion of the calcium should enter across the sarcolemmal membrane. In support of this are preliminary experiments from an in vitro model of cardiocyte differentiation from embryonic stem and embryonic carcinoma cells. In immature cardiomyocytes isolated from this system, excitationcontraction coupling does in fact appear to be much less Ž . SR dependent than those from adult cells unpublished .
Transcription of the cardiac NCX gene starts from at least 5 different points spaced over about 80 nucleotides. The structure of the cardiac NCX promoter may explain the variety of start sites of transcription seen by 5 X RPA. No consensus TATA or CAAT box have been found in the proximal promoter. The major transcription start site has Ž the consensus sequence of an initiator element Py-Py-A-. N-TrA-Py-Py and the two adjacent transcription sites resemble this consensus sequence very closely. In general, the regulation of the use of these start sites remains unclear, however, a number of potential cis-regulatory elements have been identified, including binding sites for Ž . GATA, NKX2.5, a TRE half-site y2203 , and a SRE Ž . y102 that may play an important role in the transcriptional regulation of this gene. At least 13 GATA consensus Ž . sequences GrT-GATA-ArG can be found in the y2800 bp upstream region, three of which are located in the y200 bp proximal promoter region. Members of the GATA family of transcription factors have already been shown to play an important role in cardiac development. GATA4 is expressed solely in cardiac muscle and some endodermally-derived tissues. Although only seen in the most caudal part of the heart at first, GATA4 expression eventually involves the whole heart tube. Since GATA4 regulates the expression of other cardiac genes, including w x a-MHC and Troponin C 65 , the presence of GATA sequences and their close proximity to NKX2.5 consensus elements implies an involvement of these transcription Ž . factors in the regulation of cardiac isoform s of NCX1.
Potential splicing variants in the 5 X untranslated region and the cytosolic loop with development were also examw x ined 63,66 . No major changes in the ratio of the different transcripts were found. We do, however, report the sequence of a previously unreported 5 X splice variant in rat heart as well as the existence of at least six different isoforms in the cytosolic loop. The migration of these loop PCR products as well as the use of the very 5 X brain transcription start site in heart suggests that, at least between brain and heart, there is not an exclusive tissue-restricted expression of different isoforms, but a mixture of isoforms which are preferentially expressed in particular tissues. This may help to explain some of the different functions the exchanger fulfills in any one particular tissue Ž . w x like extrusion and reabsorption 15,35-37 . Alternatively, some of the variants may arise from nerve tissues within the myocardium.
Although very few specific changes were seen in the transcription start sites or splicing with development and aging, certain aspects of NCX expression are noteworthy. First with advanced age, the abundance of NCX transcripts increase. This result is in disagreement with those pubw x w x lished by Vetter et al. 31 and Assayag et al. 67 , who reported finding no significant increase in NCX RNA expression in 24 month old versus 4 month old rats. We explain this discrepancy based on their use of a much less sensitive dot blot assay, and a difference in time points examined. We found a significant increase at 24 months only when compared to 6 and 18 month old animals, not to animals of 2 or 3 months of age. What could account for the increase? With aging, a number of genes have been shown to have altered expression including depressed expression of a-MHC and SERCA2 and an increased expression of b-MHC. Each of these genes is known to have thryoid hormone responsive elements, acting either positively or negatively, respectively. Circulating thyroid hormone is also known to be greatest at or around birth, and to decrease with age. Since hypothyroidism leads to increased NCX transcript abundance, it is possible that the circulating levels of thyroid hormone may be involved in this process.
Finally, our results predict the following scenarios. First, exchanger expression will be regulated primarily through transcriptional mechanisms, perhaps through involvement of thyroid hormone, and other trans-activating factors such as GATA4 andror NKX2.5. We have not yet identified any known hypertrophic responsive elements, w x such as those for TEF-1 binding 68,69 in the rat NCX1 cardiac-restricted promoter, but exhaustive promoter studies will be necessary to elucidate this point. Second, there are no substantial changes in the start sites of transcription nor are there any major changes in the splicing pattern of NCX transcripts throughout development. This is an important point, for if gene transfer to the diseased myocardium is to become reality, it is important to know in advance which isoforms should be introduced into the myocardium. Finally, and perhaps, most importantly, we have now identified a potential cardiac-restricted promoter that may also be responsive to stimuli for cardiac hypertrophy. As in the cases of atrial natriuretic factor, b-myosin heavy chain and myosin light chain 2 V promoter studies, this promoter should represent a fruitful avenue of research that will further our understanding of the underlying mechanisms responsible for cardiac hypertrophy. As we understand more about the molecular aspects that underlie NCX expression in the myocardium, it is hoped that this information will help us to develop new approaches towards the treatment of heart failure.
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